2001
DOI: 10.1016/s0188-4409(01)00278-8
|View full text |Cite
|
Sign up to set email alerts
|

Electrochemotherapy in Primary and Metastatic Skin Tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
71
0
1

Year Published

2003
2003
2013
2013

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 99 publications
(74 citation statements)
references
References 17 publications
2
71
0
1
Order By: Relevance
“…36,37 In addition, as oral squamous cell carcinomas frequently occur on the lips, tongue, gingiva, palate, tonsils and buccal mucosa, that type of injection is convenient. In the present study, we found that BLM (20 mg) treatment with sonoporation in the presence of Optison significantly inhibited tumor growth, as compared with the control groups ( Figure 5).…”
Section: Discussionmentioning
confidence: 99%
“…36,37 In addition, as oral squamous cell carcinomas frequently occur on the lips, tongue, gingiva, palate, tonsils and buccal mucosa, that type of injection is convenient. In the present study, we found that BLM (20 mg) treatment with sonoporation in the presence of Optison significantly inhibited tumor growth, as compared with the control groups ( Figure 5).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, (a) external electric fields generate changes in the transmembrane voltage and, under appropriate conditions, provoke the transient and reversible permeabilisation of the cells, in vitro as well as in vivo and (b) BLM molecules do not diffuse through the plasma membrane and they enter only at the time of the cell electropermeabilisation, in amounts proportional to the external concentration at the moment of EP. Moreover, permeabilising EP can be applied locally in vivo on tumour nodules: the huge increase in the antitumour effectiveness of BLM achieved by the increase in BLM uptake is the basis of electrochemotherapy (ECT), a new way to treat solid tumours that is already under clinical evaluation (Domenge et al, 1996;Mir et al, 1998;Gehl and Geertsen, 2000;Rodriguez-Cuevas et al, 2001;Rols et al, 2002). Therefore, it seemed possible to study in vivo the cell death pathway caused by different amounts of DSB using these experimental conditions.…”
mentioning
confidence: 99%
“…The chemotherapy for recurrent or metastatic tumors results in poor response rates due to the MDR and/or the relative impermeability of cell membranes to chemotherapeutics. Combined treatment consisting of pulsed electric fields and chemotherapeutic agents has been used recently as electrochemotherapy 38,39 . This treatment procedure relies on the physical effects of locally applied electric fields to destabilise cell membranes in the presence of chemotherapeutics.…”
Section: Combination Treatments and Need For Maths And Physicsmentioning
confidence: 99%